Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...

Lung cancer is the number one cancer killer in the world. Biomarker testing improves outcomes in stage IV non-small cell lung cancer (NSCLC), however its ...

Mutations in the oncogene KRAS are widespread in several human cancers, including pancreatic ductal adenocarcinomas (92%), colorectal carcinomas (49%) and lung adenocarcinomas (35%). These mutations ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Most of us would probably think of smoking or air pollution when it comes to lung cancer risk, but researchers have ...

A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...

An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

Objective: This study aims to evaluate the prognostic significance of peripheral blood biomarkers in relation to outcomes and immune-related adverse events (irAEs) among patients with stage IV driver ...

This mutation occurs in about 5% of NSCLC cases, most commonly in those with the adenocarcinoma subtype of NSCLC. The mutation causes lung cancer cells to grow and spread. Adenocarcinoma is a ...

SAN ANTONIO — If you aren't a smoker, you may think you are out of the woods when it comes to lung cancer. Not only can non-smokers get it, but a new study says the number of non-smokers getting ...

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...